National Health Investors (NYSE:NHI) Issues FY24 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $4.52-4.56 for the period, compared to the consensus EPS estimate of $4.41. National Health Investors also updated its FY 2024 guidance to 4.520-4.560 EPS.

National Health Investors Price Performance

NYSE:NHI traded up $0.11 during trading hours on Friday, reaching $74.04. The company had a trading volume of 30,265 shares, compared to its average volume of 164,872. The stock has a 50-day moving average of $69.93 and a two-hundred day moving average of $63.31. National Health Investors has a one year low of $48.51 and a one year high of $76.65. The firm has a market capitalization of $3.22 billion, a PE ratio of 24.24 and a beta of 1.02. The company has a quick ratio of 13.24, a current ratio of 13.24 and a debt-to-equity ratio of 0.91.

National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 EPS for the quarter, missing the consensus estimate of $1.10 by ($0.29). National Health Investors had a return on equity of 10.41% and a net margin of 41.40%. The business had revenue of $84.97 million for the quarter, compared to the consensus estimate of $64.95 million. During the same quarter in the previous year, the company posted $1.06 EPS. National Health Investors’s revenue for the quarter was up 9.1% on a year-over-year basis. Analysts forecast that National Health Investors will post 4.4 earnings per share for the current year.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Friday, September 27th will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.86%. The ex-dividend date is Friday, September 27th. National Health Investors’s dividend payout ratio is currently 118.03%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on NHI shares. Truist Financial increased their price objective on National Health Investors from $58.00 to $65.00 and gave the stock a hold rating in a report on Wednesday, June 26th. Wells Fargo & Company raised their price target on National Health Investors from $63.00 to $69.00 and gave the company an overweight rating in a research note on Thursday, May 30th. Finally, StockNews.com upgraded National Health Investors from a hold rating to a buy rating in a research note on Thursday. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of Moderate Buy and an average price target of $62.13.

Insider Activity at National Health Investors

In other news, Director Robert A. Mccabe, Jr. purchased 437 shares of the business’s stock in a transaction on Friday, May 31st. The shares were acquired at an average price of $65.83 per share, for a total transaction of $28,767.71. Following the completion of the acquisition, the director now owns 21,585 shares in the company, valued at $1,420,940.55. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 7.26% of the stock is owned by corporate insiders.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.